Abiopharma

Savara Inc. - Savara Announces the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) Has Accepted the MOLBREEVI* Marketing Authorisation Application (MAA) for Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)

EVAXION A/S (EVAX) Files Form 6-K

Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness

Morningstar DBRS Marks 50 Years of Credit Ratings; Advances Global Methodology Program and Asia-Pacific Growth

NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer

Academy Sports + Outdoors Announces Preliminary First Quarter Fiscal 2026 Sales Update Ahead of its Analyst Day

Savara Announces the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) Has Accepted the MOLBREEVI* Marketing Authorisation Application (MAA) for Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

📋 Darwish Mohamad (EVP, IHS Nigeria Chief Executive Officer) plans to sell 28K shares of IHS Holding Ltd (at $8.31 each, total $233K) Filed: Apr 07, 2026 | ID: 000140

New Form SCHEDULE 13G/A - abrdn Income Credit Strategies Fund <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001445546-26-002471 <b>Size:</b> 15 KB

Valeo - Voting rights - March 2026

Valeo - Déclaration des droits de vote - Mars 2026

Johnson & Johnson - Johnson & Johnson Advances Pulsed Field Ablation Portfolio with the Launch of VARIPULSE Pro in Europe

Xu Jiayuan 🟡 adjusted position in 214.2K shares (2 derivative) of FinVolution Group (FINV) Transaction Date: Apr 03, 2026 | Filing ID: 015435

Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer